dolasetron: Clinical Trials

2 trials of dolasetron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1

Follow dolasetron: new trials by email Literature Review of dolasetron trials Research Report on dolasetron

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Automated recommendation at the start of the case, Automated notification at the start of surgery, Preoperative recommendations: by email - Postoperative Nausea and Vomiting
Not applicableCompletedVanderbilt University270342016-07-012019-03-07
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
Aprepitant, Dexamethasone, Dolasetron Mesylate - Malignant Digestive System Neoplasm, Nausea and Vomiting
Not applicableTerminatedUniversity of Southern California192006-04-192017-03-28

Conditions studied

Gastrointestinal Neoplasms (1)  ·  Nausea (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Vomiting (1)

Sponsors

University of Southern California (1)  ·  Vanderbilt University (1)

Countries

United States (2)

Top investigators

Betty Chan (1)  ·  Jonathan P Wanderer, MD, MPhil (1)

NIH funding

P30CA014089 (1)